Search CDDW 2006 Abstracts

HOME

Return to Table of Contents

19

STIMULUS SPECIFIC ROLE FOR FER TYROSINE KINASE IN NEUTROPHIL RECRUITMENT: ROLE OF p38 MAPK AND PI3 KINASE

M Khajah, G Andonegui, D-M McCafferty
Gastrointestinal Research Group, University of Calgary, Calgary, Alberta

Neutrophil recruitment and directional movement toward chemotactic stimuli are important processes in the innate immune response. This study examines if Fer PTK plays a role in neutrophil recruitment and chemotaxis to various stimuli in vivo and in vitro.
Mice targeted with a kinase-inactivating mutation (FERDR/DR) or wild types (WT) were used. In vivo time-lapse intravital microscopy was used to examine leukocyte recruitment and chemotaxis in response to keratinocyte-derived cytokine (KC; 5.2 µM) or chemotactic peptide WKYMVm (0.1 µM). In WT and FERDR/DR no difference in chemotaxis in response to KC was observed. However, in response to WKYMVm a twofold increase in leukocyte emigration was noted in FERDR/DR mice (P<0.05). Bone marrow chimeras, where FERDR/DR received WT bone marrow, showed similar chemotaxis to WT in response to WKYMVm suggesting that endothelial Fer kinase was not playing a role in chemotaxis.
In vitro neutrophil chemotaxis was assessed with bone marrow derived neutrophils using an under agarose gel assay. No difference in chemotaxis was noted between WT and FERDR/DR mice in response to KC in vitro. However, a twofold increase in chemotaxis was noted in FERDR/DR vs WT neutrophils in response to WKYMVm. This chemotactic response was inhibited by two p38 MAPK inhibitors (SKF86002 and SB203580) in WT mice but not in FERDR/DR mice suggesting a regulatory role for Fer kinase on the p38 MAPK pathway. Interestingly, in FERDR/DR mice a role for the PI3 kinase pathway in chemotaxis was revealed using a PI3 kinase inhibitor (LY294002).
These data suggest that Fer kinase regulates neutrophil chemotaxis in response to WKYMVm through the regulation of p38 MAPK signalling pathway.
This work is funded by a Canadian Institutes of Health Research operating grant

PREVIOUS     NEXT